Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BMY Bristol Myers Squibb Co
- Stocks
- Healthcare
- NYSE: BMY
Price (delayed)
$46.89
Market cap
$95.42B
P/E Ratio
17.5
Dividend/share
$2.44
EPS
$2.68
Enterprise value
$134.26B
Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease,
Highlights
The net income has surged by 188% year-on-year and by 161% since the previous quarter
Bristol Myers Squibb's EPS has surged by 187% YoY and by 161% QoQ
The gross margin has decreased by 7% YoY
Bristol Myers Squibb's gross profit has decreased by 2.6% YoY and by 2.2% from the previous quarter
Key stats
What are the main financial stats of BMY
Market
Valuations
Earnings
Shares outstanding
2.04B
Market cap
$95.42B
Enterprise value
$134.26B
Price to earnings (P/E)
17.5
Price to book (P/B)
5.47
Price to sales (P/S)
2
EV/EBIT
22.05
EV/EBITDA
9.48
EV/Sales
2.82
Revenue
$47.64B
Gross profit
$33.57B
Operating income
$6.11B
Net income
$5.42B
EBIT
$6.09B
EBITDA
$14.17B
Free cash flow
$13.09B
Per share
Balance sheet
Liquidity
EPS
$2.68
EPS diluted
$2.67
Free cash flow per share
$6.45
Book value per share
$8.57
Revenue per share
$23.47
TBVPS
$23.75
Total assets
$92.43B
Total liabilities
$74.98B
Debt
$49.71B
Equity
$17.39B
Working capital
$6.71B
Debt to equity
2.86
Current ratio
1.28
Quick ratio
0.94
Net debt/EBITDA
2.74
Margins
Efficiency
Dividend
EBITDA margin
29.7%
Gross margin
70.5%
Net margin
11.4%
Operating margin
12.8%
Return on assets
5.8%
Return on equity
31.9%
Return on invested capital
9.5%
Return on capital employed
8.9%
Return on sales
12.8%
Dividend yield
5.2%
DPS
$2.44
Payout ratio
91%
BMY stock price
How has the Bristol Myers Squibb stock price performed over time
Intraday
0.09%
1 week
-2.05%
1 month
-2.11%
1 year
13.7%
YTD
-17.1%
QTD
-23.12%
Financial performance
How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$47.64B
Gross profit
$33.57B
Operating income
$6.11B
Net income
$5.42B
Gross margin
70.5%
Net margin
11.4%
The operating margin has surged by 200% year-on-year and by 174% since the previous quarter
The net income has surged by 188% year-on-year and by 161% since the previous quarter
BMY's net margin has soared by 184% year-on-year and by 162% since the previous quarter
The operating income has surged by 173% since the previous quarter
Price vs fundamentals
How does BMY's price correlate with its fundamentals
Growth
What is Bristol Myers Squibb's growth rate over time
Valuation
What is Bristol Myers Squibb stock price valuation
P/E
17.5
P/B
5.47
P/S
2
EV/EBIT
22.05
EV/EBITDA
9.48
EV/Sales
2.82
Bristol Myers Squibb's EPS has surged by 187% YoY and by 161% QoQ
BMY's P/B is 19% above its 5-year quarterly average of 4.6 but 13% below its last 4 quarters average of 6.3
Bristol Myers Squibb's equity has increased by 6% from the previous quarter and by 5% YoY
The price to sales (P/S) is 33% less than the 5-year quarterly average of 3.0 and 13% less than the last 4 quarters average of 2.3
The company's revenue rose by 4.6% YoY
Efficiency
How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's return on sales has surged by 199% YoY and by 174% QoQ
Bristol Myers Squibb's ROA has soared by 189% YoY and by 162% from the previous quarter
BMY's return on invested capital has surged by 187% year-on-year and by 173% since the previous quarter
The ROE has soared by 160% from the previous quarter
Dividends
What is BMY's dividend history
DPS
$2.44
Dividend yield
5.2%
Payout ratio
91%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Bristol Myers Squibb financials performed over time
BMY's total assets is 23% greater than its total liabilities
The quick ratio has increased by 21% YoY and by 3.3% QoQ
Bristol Myers Squibb's current ratio has increased by 15% YoY and by 2.4% from the previous quarter
BMY's debt is 186% greater than its equity
The company's debt to equity fell by 15% YoY and by 6% QoQ
BMY's debt is down by 11% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.